NØX Peptides Featured on Yahoo! Finance

NØX Peptides is pleased to be featured on Yahoo! Finance. Below is a summary and a link to the full article.

The article is essentially an announcement from NØX Peptides about updated quality-control and third-party testing information for its Wolverine Stack, a research blend containing BPC-157 and TB-500.

The main emphasis is product quality, testing transparency, purity, and traceability, rather than announcing a new peptide or clinical discovery.

The key points are:

Wolverine Stack combines BPC-157 and TB-500, with the NØX product listed as 10 mg BPC-157 + 10 mg TB-500.
NØX highlights independent analytical testing as part of its quality-control approach, including purity and endotoxin reports.
One June 1, 2026 Wolverine Stack test published by NØX reports 99.80% average purity and an average measured mass of 24.23 mg for lot NX-BPTB20-B0511-01.
Other Wolverine Stack batches listed by the company reported 99.99% purity / 20.83 mg average mass on May 25 and 99.82% purity / 23.86 mg average mass on May 22.
NØX’s broader message is that customers/researchers should be able to verify batch-specific testing instead of relying only on a supplier’s purity claims. Its lab-results page provides search codes, lot numbers, purity information, mass measurements, and links to purity and endotoxin reports.
The company positions the updated information as part of a larger emphasis on documented traceability and quality assurance for research peptides.